1Koster K. Endateriitis und arteriitis[J]. Klin Wochenschr.1876(13) :454-455.
2Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclemtic lesions[ J ]. Circulation. 1998,98 ( 20 ) : 2108-2116.
3Chen Y X, Nakashima Y, Tanaka K, et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries [ J ]. Arteosclerosis, thrombosis, andvascular biology. 1999,19( 1 ) : 131 - 139.
4Li J, Perrella M, Tsai JC, et al. Induction of vascular endothelial growth factor gene expression by interlukin- 1βin rat aortic smooth muscle cells[J]. Journal of biochemistry.1995,270 ( 1 ) : 308- 312.
5Alan N, Kevin G, Michael HS, et al. Neovascularization in atherectomy specimens from patients with unstable angina:Implications for pathogenesis of unstable angina[J ]. American heart journal. 1998,135 : 10- 14.
6O' Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronary atherosclemtic plaques[J ]. American journal of pathology. 1994,145(4) :883-894.
7Zachary I, Mathur A, Yla - Herttuala S, et al. Vascular protection: a novel, non- angiogenic cardiovascular role for vascular endothelial growth faetor[J ]. Arteosclerosis, thrombosis, and vascular biology. 2000,20 : 1512- 1520.
8Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental Hypercholesterolemia independent of lipid lowering[J ]. Circulation, 2002,105(4) :415-420.
9Loic V, Claudine S, Farroch M, et al. Cerivastatin, an inhibitor of 3 - hydroxy - 3 - methylglutaryl coenzyrne A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models[J ]. Arteoselerosis, thrombosis, and vascular biology,2002,22: 623- 629.
